The elastase-inhibitor eglin has no effect in an ovine model of endotoxemia.
Small doses of endotoxin have been shown to induce pulmonary microvascular injury in sheep, possibly by the action of granulocytes. Eglin, a potent inhibitor of neutrophil elastase, was tested in an ovine model of endotoxemia. The experiment was performed in 12 unanesthetized chronically instrumented sheep with a lung lymph preparation. Endotoxin (S. abort. equii) was infused at 24 ng/(kg x h) with application of 20 mg/kg eglin 1 h before endotoxin in the treatment group and followed by 5 mg/(kg x h). No significant improvement due to the treatment was seen for either cardiovascular status (pulmonary and systemic vascular resistance) or permeability changes in the lung (lymph flow and lymph/plasma protein ratio), although sufficient eglin concentrations were achieved in plasma and lymph. The lack of an effect of eglin might be because higher concentrations are needed to block elastase-like activity of ovine granulocytes or because of a minor role for neutrophil elastase in this shock model.
Redl
H
H
Ludwig-Boltzmann-Institut für experimentelle Traumatologie, Wien.
Schlag
G
G
Vogl
C
C
Schiesser
A
A
Paul
E
E
Thurnher
M
M
Junger
W
W
Traber
L D
LD
Traber
D L
DL
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004731:Endotoxins; D004926:Escherichia coli; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007958:Leukocyte Count; D008208:Lymphatic System / Q000187:drug effects; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors*; D011506:Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015843:Serpins; D012756:Sheep; D013929:Thromboxane B2 / Q000097:blood; D014115:Toxemia / Q000188:drug therapy*
D004731:Endotoxins; D011506:Proteins; D015843:Serpins; C028656:eglin proteinase inhibitors; D013929:Thromboxane B2; D010196:Pancreatic Elastase